New review recommends a balanced and measured approach to adopting AI in clinical practice

November 24, 2025 BioPharma Other Health

This is a preview of subscriber content

Subscribe now to continue reading.

The authors, including Queensland-based academics and health officials, argue that although enthusiasm is high, the successful adoption of AI will require a more deliberate, structured and risk-aware approach. …

Subscribe now to continue reading.

Latest Video

Georgia Forrest

Another potential turning point for immunotherapy access in Australia
February 1, 2026 - Latest News
Sandoz adds to vision care options with the listing of biosimilar
February 2, 2026 - Latest News
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - Australian Biotech
An announcement that cost more than the listing, because it would have actually cost something
February 1, 2026 - Latest News
If you're going to pay for reforms, are these the changes you want to pay for?
February 3, 2026 - Latest News

New review recommends a balanced and measured approach to adopting AI in clinical practice

This is a preview of subscriber content

Latest Video

Most Read

Another potential turning point for immunotherapy access in Australia

Sandoz adds to vision care options with the listing of biosimilar

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

An announcement that cost more than the listing, because it would have actually cost something

If you're going to pay for reforms, are these the changes you want to pay for?

New Stories

Medicines Australia calls for Budget action to restore access to innovative medicines

Survey exposes deep gaps in support for Australians living with rare cancers

Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down

AusBiotech and Medicines Australia unite to accelerate advanced therapies

If you're going to pay for reforms, are these the changes you want to pay for?

Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy

AusBiotech urges adoption of national life sciences strategy as global competition intensifies

Sign In

New review recommends a balanced and measured approach to adopting AI in clinical practice

This is a preview of subscriber content

Latest Video

Most Read

Another potential turning point for immunotherapy access in Australia

Sandoz adds to vision care options with the listing of biosimilar

PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history

An announcement that cost more than the listing, because it would have actually cost something

If you're going to pay for reforms, are these the changes you want to pay for?

Follow Us

New Stories

Medicines Australia calls for Budget action to restore access to innovative medicines

Survey exposes deep gaps in support for Australians living with rare cancers

Juvenile Arthritis Foundation Australia seeks new CEO as Angela McKay steps down

AusBiotech and Medicines Australia unite to accelerate advanced therapies

If you're going to pay for reforms, are these the changes you want to pay for?

Arthritis Australia appoints Louise Hardy as CEO at pivotal moment for national advocacy

AusBiotech urges adoption of national life sciences strategy as global competition intensifies